378 related articles for article (PubMed ID: 12695160)
1. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Riente L; Chimenti D; Pratesi F; Delle Sedie A; Tommasi S; Tommasi C; Bombardieri S; Migliorini P
J Rheumatol; 2004 May; 31(5):920-4. PubMed ID: 15124251
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA.
Török HP; Glas J; Gruber R; Brumberger V; Strasser C; Kellner H; Märker-Hermann E; Folwaczny C
Digestion; 2004; 70(1):49-54. PubMed ID: 15308872
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease.
Rodrigues IK; Andrigueti M; de Oliveira Gil ID; de Lucca Schiavon L; de Andrade KR; Pereira IA; de Castro GR; Zimmermann AF; Saporiti LN; Bazzo ML; Neves FS
Rheumatol Int; 2015 Feb; 35(2):359-66. PubMed ID: 25119827
[TBL] [Abstract][Full Text] [Related]
5. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment.
Aydin SZ; Atagunduz P; Temel M; Bicakcigil M; Tasan D; Direskeneli H
Rheumatology (Oxford); 2008 Feb; 47(2):142-4. PubMed ID: 18160421
[TBL] [Abstract][Full Text] [Related]
6. Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis.
Andretta MA; Vieira TD; Nishiara R; Skare TL
Rheumatol Int; 2012 Feb; 32(2):551-4. PubMed ID: 21305298
[TBL] [Abstract][Full Text] [Related]
7. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
[TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
[TBL] [Abstract][Full Text] [Related]
9. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
[TBL] [Abstract][Full Text] [Related]
10. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
11. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.
Van Kemseke C; Belaïche J; Steeman C; Louis E
Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease.
Duarte-Silva M; Afonso PC; de Souza PR; Peghini BC; Rodrigues-Júnior V; de Barros Cardoso CR
Autoimmunity; 2019 Feb; 52(1):37-47. PubMed ID: 30884988
[TBL] [Abstract][Full Text] [Related]
15. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
[TBL] [Abstract][Full Text] [Related]
17. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
Cooper R; Fraser SM; Sturrock RD; Gemmell CG
Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies in Behçet's disease--a familial study.
Monselise A; Weinberger A; Monselise Y; Fraser A; Sulkes J; Krause I
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S87-90. PubMed ID: 17067434
[TBL] [Abstract][Full Text] [Related]
19. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease.
Oshitani N; Hato F; Matsumoto T; Jinno Y; Sawa Y; Hara J; Nakamura S; Seki S; Arakawa T; Kitano A; Kitagawa S; Kuroki T
J Gastroenterol Hepatol; 2000 Dec; 15(12):1400-3. PubMed ID: 11197050
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
Giaffer MH; Clark A; Holdsworth CD
Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
